Posted December 22, 2017
The U.S. Food and Drug Admininstration (FDA) has proposed a new risk-based enforcement approach to drugs labeled as homeopathic. Many homeopathic treatments are being marketed as remedies for serious diseases and conditions when there is no actual proof the products provide clinical benefits, FDA says. Read more.